DexaDagen-2 study : Double blind placebo controlled randomized intervention study to validate the beneficial effect of hydrocortisone on dexamethasone-induced neurobehavioral side effects in pediatric acute lymphoblastic leukemia.

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Unbestimmt

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Acute lymphoblastic leukemia, behavior, sleep, mood, quality of life, frailty
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2017-09-05, Last updated: 2023-04-06

ICTRP ID:

NTR6695
NL6507
NL62388.078.17 : ABR 62388

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG006935184